PlexBio Co., Ltd. engages in research, development, manufacture, and sale of medical testing equipment and reagents. Its products include in vitro diagnostic companion diagnostic kits, detection and genotyping diagnostic kits, nucleic acid extraction kits, and life science and research reagent kits. It also offers fluorescent analyzers, code processors, molecular assay and immunoassay automation systems, and trio nucleic acid extraction systems. The company founded on December 17, 2009 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company